Author/Authors :
Hernandez-Baltazar, Daniel CONACYT-Instituto de Neuroetologia - Universidad Veracruzana - Xalapa - Veracruz, Mexico , Nadella, Rasajna IIIT Srikakulam - Rajiv Gandhi University of Knowledge Technologies (RGUKT) - International collaboration ID:1840; India , Mireya Zavala-Flores, Laura Centro de Investigacion Biomedica del Noreste - IMSS. Monterrey - Nuevo Leon. Mexico , Rosas-Jarquin, Christian de Jesús Instituto de Neuroetologia - Universidad Veracruzana - Xalapa - Veracruz, Mexico , Jesús Rovirosa-Hernandez, María de Instituto de Neuroetologia - Universidad Veracruzana - Xalapa - Veracruz, Mexico , Villanueva-Olivo, Arnulfo Facultad de Medicina - Universidad Autonoma de Nuevo Leon - Monterrey - Nuevo Leon, Mexico
Abstract :
Objective(s): Parkinson’s disease (PD) is characterized by motor and cognitive dysfunctions. The
progressive degeneration of dopamine-producing neurons that are present in the substantia nigra
pars compacta (SNpc) has been the main focus of study and PD therapies since ages.
Materials and Methods: In this manuscript, a systematic revision of experimental and clinical evidence of
PD-associated cell process was conducted.
Results: Classically, the damage in the dopaminergic neuronal circuits of SNpc is favored by reactive
oxidative/nitrosative stress, leading to cell death. Interestingly, the therapy for PD has only focused
on avoiding the symptom progression but not in finding a complete reversion of the disease. Recent
evidence suggests that the renin-angiotensin system imbalance and neuroinflammation are the main
keys in the progression of experimental PD.
Conclusion: The progression of neurodegeneration in SNpc is due to the complex interaction of
multiple processes. In this review, we analyzed the main contribution of four cellular processes and
discussed in the perspective of novel experimental approaches.
Keywords :
Cell death , Dopaminergic neurons , Inflammation , Survival , Therapeutics